KIMBERLY RIVERS: Open Payments
NPI 1417347071 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 134 payments from 19 companies in 2025. Trend: 2023 $1,848 · 2024 $2,053 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $332 |
| ABBVIE INC. | 19 | $274 |
| Alkermes, Inc. | 15 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $224 |
| Tris Pharma Inc | 12 | $222 |
| Otsuka America Pharmaceutical, Inc. | 15 | $212 |
| Corium, LLC | 12 | $199 |
| Janssen Pharmaceuticals, Inc | 5 | $119 |
| Noven Therapeutics, LLC | 6 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $97 |
Products named: Auvelity, VRAYLAR, ARISTADA, REXULTI, CAPLYTA, Dyanavel XR, Azstarys, SPRAVATO.
Industry payments across LA — which companies pay providers there.
